BioCardia Future Growth
Future criteria checks 2/6
BioCardia is forecast to grow earnings and revenue by 26.6% and 68.6% per annum respectively while EPS is expected to grow by 34.6% per annum.
Key information
26.6%
Earnings growth rate
34.6%
EPS growth rate
Biotechs earnings growth | 21.3% |
Revenue growth rate | 68.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Nov 2023 |
Recent future growth updates
Recent updates
Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns
Oct 12BioCardia stock rises on contract for delivery products for BlueRock's cell therapies
Aug 24Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?
Aug 24Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation
May 10We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully
Jan 06We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully
Sep 23Why I've Taken A Small Position In BioCardia
Jun 14Shareholders May Not Be So Generous With BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation And Here's Why
Jun 08Is BioCardia (NASDAQ:BCDA) In A Good Position To Deliver On Growth Plans?
May 20BioCardia issued U.S. patent for Helix Biotherapeutic Delivery system
Dec 30BioCardia slips 11% on launch of direct offering
Dec 16BioCardia says DSMB feedback on cell therapy data in heart failure study anticipated soon
Dec 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6 | -19 | N/A | N/A | 1 |
12/31/2025 | 1 | -19 | N/A | N/A | 1 |
12/31/2024 | 1 | -16 | N/A | N/A | 1 |
12/31/2023 | 0 | -12 | -10 | -10 | N/A |
9/30/2023 | 1 | -13 | -11 | -11 | N/A |
6/30/2023 | 0 | -13 | -11 | -11 | N/A |
3/31/2023 | 1 | -12 | -10 | -10 | N/A |
12/31/2022 | 1 | -12 | -11 | -11 | N/A |
9/30/2022 | 1 | -12 | -11 | -11 | N/A |
6/30/2022 | 2 | -12 | -11 | -11 | N/A |
3/31/2022 | 1 | -13 | -12 | -11 | N/A |
12/31/2021 | 1 | -13 | -10 | -10 | N/A |
9/30/2021 | 1 | -12 | -11 | -11 | N/A |
6/30/2021 | 0 | -13 | -12 | -12 | N/A |
3/31/2021 | 0 | -13 | -11 | -11 | N/A |
12/31/2020 | 0 | -15 | -12 | -12 | N/A |
9/30/2020 | 0 | -16 | -12 | -12 | N/A |
6/30/2020 | 0 | -15 | -10 | -10 | N/A |
3/31/2020 | 1 | -16 | -10 | -10 | N/A |
12/31/2019 | 1 | -15 | -10 | -9 | N/A |
9/30/2019 | 1 | -15 | -10 | -9 | N/A |
6/30/2019 | 0 | -15 | -10 | -10 | N/A |
3/31/2019 | 1 | -14 | -11 | -10 | N/A |
12/31/2018 | 1 | -14 | -11 | -11 | N/A |
9/30/2018 | 1 | -14 | -10 | -10 | N/A |
6/30/2018 | 1 | -13 | -10 | -10 | N/A |
3/31/2018 | 1 | -13 | -10 | -9 | N/A |
12/31/2017 | 0 | -12 | -9 | -9 | N/A |
9/30/2017 | 1 | -12 | N/A | -9 | N/A |
6/30/2017 | 1 | -13 | N/A | -8 | N/A |
3/31/2017 | 1 | -12 | N/A | -7 | N/A |
12/31/2016 | 1 | -10 | N/A | -6 | N/A |
9/30/2016 | 1 | -7 | N/A | -4 | N/A |
6/30/2016 | 1 | -7 | N/A | -5 | N/A |
3/31/2016 | 1 | -6 | N/A | -6 | N/A |
12/31/2015 | 1 | -7 | N/A | -7 | N/A |
3/31/2015 | 1 | -10 | N/A | -6 | N/A |
12/31/2014 | 1 | -10 | N/A | -6 | N/A |
12/31/2013 | 2 | -6 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BCDA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BCDA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BCDA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BCDA's revenue (68.6% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: BCDA's revenue (68.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BCDA's Return on Equity is forecast to be high in 3 years time